Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 15 results for "dcgi"

Regenerative Medical Services receives DCGI nod for cell thera...

Chondron ACI is indicated for use of articular cartilage defects of knee, ankle & shoulder joints BS B2B Bureau | Mumbai April 13, 2017 Last Updated at 16:04 IST The Mumbai-based Regenerative Medical Services Regrow (RMS Regrow) has received market ... Business Standard, 1 week ago

4 images for dcgi

Money Control, 1 month ago, 2 months ago
Indian Express, 3 months ago
Indian Express, 5 months ago

The division bench did not approve of the single judge's

The division bench today said the directions given to DCGI by the single judge shall not be operational till the next date of hearing.
 DNA1 month ago
Money Control

Biocon, Mylan breast cancer drugs approved by DCGI: HC told

Swiss pharma major Roche cannotprima facie have a say against the sale and marketing ofbreast cancer medicines of drug firms Biocon and Mylan oncethe Drugs Controller General of India (DCGI) has approved it,Delhi High Court said today.
 Money Control1 month ago Can Biocon, Mylan drugs be used for early breast cancer: HC  Business Standard2 months ago

Govt invokes emergency clause to maintain supply of stents

The government has asked stent manufacturers to maintain uninterrupted supply of coronary stents by invoking emergency clause in public interest. The move comes in the wake of various multinationals, including Abbott Healthcare and India Medtronic, seeking ...
 Deccan Herald17 hours ago

HC allows Biocon, Mylan to sell their drug for three cancers

The Delhi High Court today allowed drug companies Biocon and Mylan to sell their version of Trastuzumab for two kinds of breast cancer and metastatic gastric cancer in view of the approval granted to it by the Drugs Controller General of India (DCGI).
 DNA1 month ago

Govt to act against cos creating artificial shortage of stents

Government today said it is keeping a close watch on some companies trying to create an artificial shortage of life-saving coronary stents and stringent action will taken against those engaging in unethical practices. There are reports of shortages of stents ...
 Business Standard2 months ago

Pollux embarks on training mission

Taking a cue from the Drug Controller General of India's circular, skill development firm Pollux has drawn an initial training calendar to empower 5,000 personnel across pharmaceutical clusters in Maharashtra. Pollux has been mandated by Life Science Sector ...
 Business Standard2 months ago

Sensex Closes in Red; Economic Survey Fails to Cheer Market

Posted by Equitymaster Share markets in India finished the day on a negative note as Finance Minister Arun Jaitley tabled Economic Survey for 2016-17. The Survey has projected the growth rate for the current fiscal at 6.5%, lower than 7.1% projected by ...
 Equitymaster.com2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less